the unmet need in dlbcl
Published 8 years ago • 172 plays • Length 0:43Download video MP4
Download video MP3
Similar videos
-
1:09
areas of unmet need for dlbcl: primary refractory disease and double-hit lymphoma
-
1:16
unmet needs in second-line dlbcl and challenges in this space
-
1:34
advances and unmet needs in second-line treatment of dlbcl
-
1:13
second-line treatment strategies for patients with relapsed dlbcl
-
1:02
the changing standard of care in dlbcl
-
2:32
unmet needs in t-cell lymphoma and the importance of better understanding disease biology
-
1:34
unmet needs in t-cell lymphoma
-
7:31
t-cell lymphoma with barbara pro, md | everything you need to know
-
4:37
this is blood cancer: bd
-
3:13
imaging in lymphoma with thomas habberman, md | everything you need to know about blood cancer
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
1:52
unmet needs in the treatment of t-cell malignancies
-
7:16
changes in the classification of dlbcl
-
3:21
safety management of car-t cell therapy in dlbcl
-
2:23
re-mind2: observational study comparing tafasitamab lenalidomide to available therapies in r/r dlbcl
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
4:59
a breakthrough therapy: polatuzumab vedotin plus br for r/r dlbcl
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
1:21
major unmet needs in ptcl
-
3:04
applying molecular understanding of dlbcl to management strategies
-
1:53
the current immunotherapeutic landscape for treatment of dlbcl
-
1:22
unmet needs in bpdcn